反応式
[S:1]([C:4]1[CH:25]=[CH:24][C:7]2[N:8]=[C:9]([NH:11][C:12]([NH:14][CH2:15][CH2:16][N:17]3[CH2:22][CH2:21][N:20]([CH3:23])[CH2:19][CH2:18]3)=[O:13])[S:10][C:6]=2[CH:5]=1)C#N.SCC(C(CS)O)O>P([O-])(O)(O)=O.[K+]>[CH3:23][N:20]1[CH2:19][CH2:18][N:17]([CH2:16][CH2:15][NH:14][C:12]([NH:11][C:9]2[S:10][C:6]3[CH:5]=[C:4]([SH:1])[CH:25]=[CH:24][C:7]=3[N:8]=2)=[O:13])[CH2:22][CH2:21]1参加物
4
実験手順
The 1-[2-(4-methylpiperazin-1-yl)ethyl]-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea was prepared according to the method described in Example 1b, but using 1 g of 1-(6-thiocyanato-1,3-benzothiazol-2-yl)-3-[2-(4-methylpiperazin-1-yl)ethyl]urea, 14 mg of potassium dihydrogen phosphate and 1.16 g of DL-dithiothreitol. 380 mg of 1-[2-(4-methylpiperazin-1-yl)ethyl]-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea are thus obtained in the form of a white solid, the characteristics of which are as follows:
後処理
- customThe 1-[2-(4-methylpiperazin-1-yl)ethyl]-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea was prepared
出典と根拠
- ORDレコード
- ord-f8f783ae2365465f8a08a5336683c7a8
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08546393B2
関連ノート
読み込み中…